(Q37824811)

PubMed publication ID

23 August 2017

2 references

18 December 2020

Targeting cell entry of enveloped viruses as an antiviral strategy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6259279&resulttype=core&format=json

13 May 2020

1 reference

18 December 2020

Elodie Teissier

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6259279&resulttype=core&format=json

13 May 2020

François Penin

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6259279&resulttype=core&format=json

13 May 2020

Eve-Isabelle Pécheur

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6259279&resulttype=core&format=json

13 May 2020

language of work or name

English

0 references

publication date

30 December 2010

2 references

PubMed publication ID

23 August 2017

18 December 2020

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6259279&resulttype=core&format=json

13 May 2020

18 December 2020

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6259279&resulttype=core&format=json

13 May 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6259279&resulttype=core&format=json

13 May 2020

page(s)

221-250

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6259279&resulttype=core&format=json

Creative Commons Attribution

13 May 2020

copyright license

1 reference

18 December 2020

0 references

Viral proteins function as ion channels.

1 reference

12 December 2020

Silibinin and related compounds are direct inhibitors of hepatitis C virus RNA-dependent RNA polymerase

1 reference

12 December 2020

A peptide derived from hepatitis C virus E2 envelope protein inhibits a post-binding step in HCV entry

1 reference

12 December 2020

Phosphorothioate oligonucleotides inhibit human immunodeficiency virus type 1 fusion by blocking gp41 core formation

1 reference

12 December 2020

Successful prevention of hepatitis C virus (HCV) liver graft reinfection by silibinin mono-therapy

1 reference

12 December 2020

Mapping of the hepatitis B virus attachment site by use of infection-inhibiting preS1 lipopeptides and tupaia hepatocytes

1 reference

12 December 2020

HIV entry and its inhibition

1 reference

12 December 2020

Multiple effects of silymarin on the hepatitis C virus lifecycle

1 reference

12 December 2020

Actinohivin, a novel anti-HIV protein from an actinomycete that inhibits syncytium formation: isolation, characterization, and biological activities

1 reference

12 December 2020

Hepatitis C virus entry into host cells

1 reference

12 December 2020

Peptide inhibitors of dengue virus and West Nile virus infectivity

1 reference

12 December 2020

Cyanovirin-N inhibits hepatitis C virus entry by binding to envelope protein glycans

1 reference

12 December 2020

Structures and Mechanisms of Viral Membrane Fusion Proteins: Multiple Variations on a Common Theme

1 reference

12 December 2020

The molecular basis of the specific anti-influenza action of amantadine

1 reference

12 December 2020

Class III viral membrane fusion proteins

1 reference

12 December 2020

Binding of a potent small-molecule inhibitor of six-helix bundle formation requires interactions with both heptad-repeats of the RSV fusion protein

1 reference

12 December 2020

The structural biology of type I viral membrane fusion

1 reference

12 December 2020

EWI-2wint--a host cell factor inhibiting hepatitis C virus entry.

1 reference

12 December 2020

A randomized, open-label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipients

1 reference

12 December 2020

Human occludin is a hepatitis C virus entry factor required for infection of mouse cells

1 reference

12 December 2020

Antiviral activity of chondroitin sulphate E targeting dengue virus envelope protein

1 reference

12 December 2020

Monoclonal anti-claudin 1 antibodies prevent hepatitis C virus infection of primary human hepatocytes

1 reference

12 December 2020

Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation

1 reference

12 December 2020

Milk thistle nomenclature: why it matters in cancer research and pharmacokinetic studies

1 reference

12 December 2020

Discovery of 4-benzoyl-1-[(4-methoxy-1H- pyrrolo[2,3-b]pyridin-3-yl)oxoacetyl]-2- (R)-methylpiperazine (BMS-378806): a novel HIV-1 attachment inhibitor that interferes with CD4-gp120 interactions

1 reference

12 December 2020

Orally active fusion inhibitor of respiratory syncytial virus

1 reference

12 December 2020

A virocidal amphipathic -helical peptide that inhibits hepatitis C virus infection in vitro

1 reference

12 December 2020

Rigid amphipathic fusion inhibitors, small molecule antiviral compounds against enveloped viruses

1 reference

12 December 2020

Influenza M2 proton channels

1 reference

12 December 2020

The hepatitis C virus and its hepatic environment: a toxic but finely tuned partnership

1 reference

12 December 2020

Addition of a cholesterol group to an HIV-1 peptide fusion inhibitor dramatically increases its antiviral potency

1 reference

12 December 2020

Rapamycin reduces CCR5 mRNA levels in macaques: potential applications in HIV-1 prevention and treatment

1 reference

12 December 2020

Evolution of prophylaxis: MoAb, siRNA, vaccine, and small molecules

1 reference

12 December 2020

HIV-1 entry inhibitors: an overview

1 reference

12 December 2020

Novel inhibitors of influenza virus fusion: structure-activity relationship and interaction with the viral hemagglutinin

1 reference

12 December 2020

Arbidol: a broad-spectrum antiviral that inhibits acute and chronic HCV infection

1 reference

12 December 2020

Antiviral chemotherapeutic agents against respiratory viruses: where are we now and what's in the pipeline?

1 reference

12 December 2020

Hepatitis C virus glycoproteins mediate low pH-dependent membrane fusion with liposomes

1 reference

12 December 2020

Replication of hepatitis C virus

1 reference

12 December 2020

Mode of action of an antiviral peptide from HIV-1. Inhibition at a post-lipid mixing stage

1 reference

12 December 2020

Identification and characterisation of a novel anti-viral peptide against avian influenza virus H9N2.

1 reference

12 December 2020

Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development

1 reference

12 December 2020

Structural basis of viral invasion: lessons from paramyxovirus F

1 reference

12 December 2020

Inhibition of human immunodeficiency virus (HIV-1) infection in human peripheral blood leucocytes-SCID reconstituted mice by rapamycin

1 reference

12 December 2020

Influenza A: understanding the viral life cycle

1 reference

12 December 2020

Clarithromycin inhibits type a seasonal influenza virus infection in human airway epithelial cells

1 reference

12 December 2020

Putative role of membranes in the HIV fusion inhibitor enfuvirtide mode of action at the molecular level

1 reference

12 December 2020

Hepatitis C virus NS5A anchor peptide disrupts human immunodeficiency virus

1 reference

12 December 2020

Mechanism by which the lectin actinohivin blocks HIV infection of target cells

1 reference

12 December 2020

Preclinical Evaluation of Two Neutralizing Human Monoclonal Antibodies against Hepatitis C Virus (HCV): a Potential Treatment To Prevent HCV Reinfection in Liver Transplant Patients

1 reference

12 December 2020

Mechanism of inhibition of enveloped virus membrane fusion by the antiviral drug arbidol

1 reference

12 December 2020

Hepatitis C Virus Entry Depends on Clathrin-Mediated Endocytosis

1 reference

12 December 2020

Distribution and dynamics of adamantanes in a lipid bilayer

1 reference

12 December 2020

Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein

1 reference

12 December 2020

Mechanisms of viral entry: sneaking in the front door

1 reference

12 December 2020

Structure and function of the membrane anchor domain of hepatitis C virus nonstructural protein 5A.

1 reference

12 December 2020

Amphipathic DNA Polymers Inhibit Hepatitis C Virus Infection by Blocking Viral Entry

1 reference

12 December 2020

Domain III from class II fusion proteins functions as a dominant-negative inhibitor of virus membrane fusion

1 reference

12 December 2020

Inhibition of neuraminidase inhibitor-resistant influenza virus by DAS181, a novel sialidase fusion protein

1 reference

12 December 2020

Peptide Inhibitors of Dengue-Virus Entry Target a Late-Stage Fusion Intermediate

1 reference

12 December 2020

Development of novel therapies for hepatitis C.

1 reference

12 December 2020

Essential regions for antiviral activities of actinohivin, a sugar-binding anti-human immunodeficiency virus protein from an actinomycete

1 reference

12 December 2020

Assembly of endocytic machinery around individual influenza viruses during viral entry

1 reference

12 December 2020

Respiratory syncytial virus-neutralizing monoclonal antibodies motavizumab and palivizumab inhibit fusion

1 reference

12 December 2020

Actinohivin: specific amino acid residues essential for anti-HIV activity

1 reference

12 December 2020

Drug-drug interactions of silymarin on the perspective of pharmacokinetics

1 reference

12 December 2020

Biochemical mechanism of hepatitis C virus inhibition by the broad-spectrum antiviral arbidol

1 reference

12 December 2020

A small-molecule dengue virus entry inhibitor

1 reference

12 December 2020

A ligand-binding pocket in the dengue virus envelope glycoprotein

1 reference

12 December 2020

Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies

1 reference

12 December 2020

An amino-terminal amphipathic alpha-helix mediates membrane association of the hepatitis C virus nonstructural protein 5A

1 reference

12 December 2020

The Disulfide Bonds in Glycoprotein E2 of Hepatitis C Virus Reveal the Tertiary Organization of the Molecule

1 reference

12 December 2020

Cell entry of hepatitis C virus

1 reference

12 December 2020

Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion

1 reference

12 December 2020

Adamantane resistance in influenza A.

1 reference

12 December 2020

Anti-HIV-1 activity of weekly or biweekly treatment with subcutaneous PRO 140, a CCR5 monoclonal antibody

1 reference

12 December 2020

Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein.

1 reference

12 December 2020

Viral entry inhibitors targeted to the membrane site of action.

1 reference

12 December 2020

Identification of terfenadine as an inhibitor of human CD81-receptor HCV-E2 interaction: synthesis and structure optimization

1 reference

12 December 2020

Targeting a binding pocket within the trimer-of-hairpins: small-molecule inhibition of viral fusion

1 reference

12 December 2020

Actinohivin, a broadly neutralizing prokaryotic lectin, inhibits HIV-1 infection by specifically targeting high-mannose-type glycans on the gp120 envelope

1 reference

12 December 2020

Actinohivin, a novel anti-human immunodeficiency virus protein from an actinomycete, inhibits viral entry to cells by binding high-mannose type sugar chains of gp120.

1 reference

12 December 2020

The CD81 Partner EWI-2wint Inhibits Hepatitis C Virus Entry

1 reference

12 December 2020

Anti-CD81 antibodies can prevent a hepatitis C virus infection in vivo

1 reference

12 December 2020

HIV-1 fusion inhibitor peptides enfuvirtide and T-1249 interact with erythrocyte and lymphocyte membranes

1 reference

12 December 2020

Current pharmacotherapeutic treatment options in Parkinson's disease

1 reference

12 December 2020

Characteristics of arbidol-resistant mutants of influenza virus: implications for the mechanism of anti-influenza action of arbidol

1 reference

12 December 2020

Class II virus membrane fusion proteins

1 reference

12 December 2020

Gumming up the works: DNA polymers as HCV entry inhibitors

1 reference

12 December 2020

Antiviral compounds discovered by virtual screening of small-molecule libraries against dengue virus E protein

1 reference

12 December 2020

Arbidol: a broad-spectrum antiviral compound that blocks viral fusion

1 reference

12 December 2020

Potent anti-influenza activity of cyanovirin-N and interactions with viral hemagglutinin

1 reference

12 December 2020

A small molecule fusion inhibitor of dengue virus

1 reference

12 December 2020

Lipids as modulators of membrane fusion mediated by viral fusion proteins

1 reference

12 December 2020

Herbal product use by persons enrolled in the hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial.

1 reference

12 December 2020

Virus membrane-fusion proteins: more than one way to make a hairpin

1 reference

12 December 2020

Inhibition of West Nile virus entry by using a recombinant domain III from the envelope glycoprotein.

1 reference

12 December 2020

Sialidase fusion protein as a novel broad-spectrum inhibitor of influenza virus infection.

1 reference

12 December 2020

Silibinin is a potent antiviral agent in patients with chronic hepatitis C not responding to pegylated interferon/ribavirin therapy.

1 reference

12 December 2020

Targeting the proteolytic processing of the viral glycoprotein precursor is a promising novel antiviral strategy against arenaviruses

1 reference

12 December 2020

Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry

1 reference

12 December 2020

Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes

1 reference

12 December 2020

Identification of hepatoprotective flavonolignans from silymarin

1 reference

12 December 2020

Low pH-dependent Hepatitis C Virus Membrane Fusion Depends on E2 Integrity, Target Lipid Composition, and Density of Virus Particles

1 reference

12 December 2020

Viral membrane fusion

1 reference

12 December 2020

Palivizumab utilization and compliance: trends in respiratory syncytial virus prophylaxis in Florida

1 reference

12 December 2020

Cleavage of influenza virus hemagglutinin by airway proteases TMPRSS2 and HAT differs in subcellular localization and susceptibility to protease inhibitors

1 reference

12 December 2020

Entry of hepatitis C virus and human immunodeficiency virus is selectively inhibited by carbohydrate-binding agents but not by polyanions

1 reference

12 December 2020

Distribution and three-dimensional structure of AIDS virus envelope spikes

1 reference

12 December 2020

Pharmacokinetic properties and bioequivalence of two formulations of arbidol: an open-label, single-dose, randomized-sequence, two-period crossover study in healthy Chinese male volunteers

1 reference

12 December 2020

Design, synthesis, and biological evaluation of antiviral agents targeting flavivirus envelope proteins

1 reference

12 December 2020

Herbal medicine in the treatment of liver diseases

1 reference

12 December 2020

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

1 reference

12 December 2020

Biochemical and genetic characterizations of a novel human immunodeficiency virus type 1 inhibitor that blocks gp120-CD4 interactions

1 reference

12 December 2020

Host envelope glycoprotein processing proteases are indispensable for entry into human cells by seasonal and highly pathogenic avian influenza viruses

1 reference

12 December 2020

Inhibition of influenza virus infection by a novel antiviral peptide that targets viral attachment to cells

1 reference

12 December 2020

A small-molecule oxocarbazate inhibitor of human cathepsin L blocks severe acute respiratory syndrome and ebola pseudotype virus infection into human embryonic kidney 293T cells.

1 reference

12 December 2020

The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity

1 reference

12 December 2020

Lamiridosins, hepatitis C virus entry inhibitors from Lamium album.

1 reference

12 December 2020

A novel small molecule inhibitor of hepatitis C virus entry

1 reference

12 December 2020

HIV-1 neutralization profile and plant-based recombinant expression of actinohivin, an Env glycan-specific lectin devoid of T-cell mitogenic activity

1 reference

12 December 2020

New perspectives in HCV therapy: entry inhibitors.

1 reference

12 December 2020

Viral entry mechanisms: the increasing diversity of paramyxovirus entry

1 reference

12 December 2020

A broad-spectrum antiviral targeting entry of enveloped viruses

1 reference

12 December 2020

Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States

1 reference

12 December 2020

10.3390/MOLECULES16010221

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6259279&resulttype=core&format=json

13 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6259279&resulttype=core&format=json

13 May 2020

PubMed publication ID

21193846

1 reference